Pyrazolo [1,5-a] pyrimidine derivative and nad (p) h oxidase inhibitor containing the same
US7662826B2 · kind B2 · utility
22Cited by
8References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 2003 |
| Grant date | Feb 16, 2010 |
| Priority date | — |
| Expiry date | Oct 23, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound represented by the formula (Ia) (wherein R1a, R2a, and R3 to R5 are the same as defined in the description), a prodrug thereof, a pharmaceutically acceptable salt thereof, or solvate thereof. The compounds are useful in the prevention of or treatment for diseases relating to NAD(P)H.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.